Helix BioMedix, Inc. (HXBM)
USD 7.18
(0.0%)
USD 7.18
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -2.57 Million USD | 23.57% |
| 2022 | -3.36 Million USD | 0.0% |
| 2011 | -1.68 Million USD | 58.24% |
| 2010 | -4.04 Million USD | -181.02% |
| 2009 | 4.99 Million USD | 145.9% |
| 2008 | 2.03 Million USD | 540.07% |
| 2007 | -461.29 Thousand USD | 63.87% |
| 2006 | -1.27 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 FY | -2.57 Million USD | 23.57% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1310.00 USD | -196085.649% |
| Arch Therapeutics, Inc. | 5.64 Million USD | 145.5% |
| Evofem Biosciences, Inc. | 42.79 Million USD | 106.006% |
| Nascent Biotech, Inc. | -249.62 Thousand USD | -929.578% |
| Rebus Holdings, Inc. | 305 Thousand USD | 942.633% |
| Santhera Pharmaceuticals Holding AG | -6.3 Million USD | 59.235% |
| Qrons Inc. | 351.42 Thousand USD | 831.313% |
| Adynxx, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | 622.36 Thousand USD | 512.947% |
| Northwest Biotherapeutics, Inc. | 43.43 Million USD | 105.917% |
| ProtoKinetix, Incorporated | -20.4 Thousand USD | -12493.258% |
| Skye Bioscience, Inc. | -5.72 Million USD | 55.08% |
| Eiger BioPharmaceuticals, Inc. | 15.76 Million USD | 116.304% |
| Nanobac Pharmaceuticals, Incorporated | 4.11 Million USD | 162.409% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | 739.552% |
| SQZ Biotechnologies Company | -36.23 Million USD | 92.908% |
| Intellipharmaceutics International Inc. | 2.24 Million USD | 214.619% |
| Propanc Biopharma, Inc. | 927.18 Thousand USD | 377.186% |
| Mesoblast Limited | 55.85 Million USD | 104.601% |
| Marizyme, Inc. | 18.56 Million USD | 113.84% |
| Genus plc | 190.6 Million USD | 101.348% |
| VioQuest Pharmaceuticals, Inc. | 2.23 Million USD | 214.947% |
| Pharming Group N.V. | 109.8 Million USD | 102.341% |
| Therapeutic Solutions International, Inc. | 860.24 Thousand USD | 398.757% |
| CNBX Pharmaceuticals Inc. | 1.21 Million USD | 311.719% |
| Nymox Pharmaceutical Corporation | 680 Thousand USD | 477.946% |
| ContraFect Corporation | -6.02 Million USD | 57.351% |
| PsyBio Therapeutics Corp. | 134.63 Thousand USD | 2008.832% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.15 Million USD | 322.431% |
| IMV Inc. | 7.67 Million USD | 133.505% |
| AXIM Biotechnologies, Inc. | 5.5 Million USD | 146.712% |
| MultiCell Technologies, Inc. | 90.04 USD | 2854422.523% |
| ONE Bio Corp. | 9.04 Million USD | 128.429% |
| Accustem Sciences Inc. | -733.97 Thousand USD | -250.151% |
| RVL Pharmaceuticals plc | 12.94 Million USD | 119.852% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | 1.36 Million USD | 287.872% |
| Q BioMed Inc. | 4.06 Million USD | 163.301% |
| Emmaus Life Sciences, Inc. | 30.55 Million USD | 108.411% |
| Mosaic ImmunoEngineering Inc. | 1 Million USD | 355.035% |
| Biomind Labs Inc. | 711.4 Thousand USD | 461.263% |
| American Oriental Bioengineering, Inc. | 60.54 Million USD | 104.245% |
| Provectus Biopharmaceuticals, Inc. | 1.99 Million USD | 228.541% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | 12.8 Million USD | 120.068% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | 814.473% |
| THC Farmaceuticals, Inc. | 139.8 Thousand USD | 1938.311% |
| Acro Biomedical Co., Ltd. | 19.86 Thousand USD | 13036.186% |
| Curative Biotechnology, Inc. | 2.2 Million USD | 216.715% |
| GB Sciences, Inc. | 1.74 Million USD | 247.085% |
| Alpha Cognition Inc. | -183.78 Thousand USD | -1298.368% |
| HST Global, Inc. | 96.79 Thousand USD | 2755.184% |
| CSL Limited | 10.52 Billion USD | 100.024% |
| Wesana Health Holdings Inc. | 206.21 Thousand USD | 1346.276% |
| Halberd Corporation | 144.72 Thousand USD | 1875.853% |
| Enzolytics Inc. | 981.65 Thousand USD | 361.806% |
| Agentix Corp. | 37.63 Thousand USD | 6929.561% |
| Resverlogix Corp. | 6.45 Million USD | 139.839% |
| Nuo Therapeutics, Inc. | -673.08 Thousand USD | -281.826% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -2.02 Billion USD | 99.873% |
| Enzon Pharmaceuticals, Inc. | -47.01 Million USD | 94.533% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | 136.346% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | 194.884% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -8.83 Million USD | 70.927% |
| AVAX Technologies, Inc. | -5.9 Million USD | 56.464% |
| Zenith Capital Corp. | 10.06 Thousand USD | 25636.884% |
| Genscript Biotech Corporation | -1.06 Billion USD | 99.758% |
| Ember Therapeutics, Inc. | 200.43 Thousand USD | 1382.246% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | 2.38 Million USD | 207.711% |
| WPD Pharmaceuticals Inc. | 164.5 Thousand USD | 1662.244% |
| Cotinga Pharmaceuticals Inc. | -18.31 Thousand USD | -13930.091% |
| Kadimastem Ltd | -253.1 Thousand USD | -915.414% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | 20.27 Million USD | 112.675% |
| BioStem Technologies, Inc. | 4.47 Million USD | 157.469% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | 201.25 Thousand USD | 1377.009% |
| LadRx Corporation | -2.03 Million USD | -26.2% |
| Cell Source, Inc. | 9.23 Million USD | 127.838% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | 504.623% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | 504.623% |
| NovAccess Global Inc. | 2.17 Million USD | 217.974% |
| Affymax, Inc. | -5.59 Million USD | 54.082% |
| Itoco Inc. | 228.3 Thousand USD | 1225.701% |
| Rasna Therapeutics, Inc. | 135.98 Thousand USD | 1989.882% |
| Pathfinder Cell Therapy, Inc. | 4.95 Million USD | 151.847% |
| Mobile Lads Corp. | 484.23 Thousand USD | 630.744% |
| CytoDyn Inc. | 20.26 Million USD | 112.684% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -647.00 USD | -397122.875% |
| NanoSphere Health Sciences Inc. | -9268.34 USD | -27629.151% |
| Alseres Pharmaceuticals, Inc. | 7.7 Million USD | 133.351% |
| SYBLEU INC | 473.71 Thousand USD | 642.528% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 4.45 Million USD | 157.663% |
| International Stem Cell Corporation | 2.59 Million USD | 199.229% |
| Bioxytran, Inc. | 1.89 Million USD | 235.342% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | 4217.783% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | 217.843% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | 3.43 Million USD | 174.841% |
| Adhera Therapeutics, Inc. | 8.55 Million USD | 130.048% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | 772.6 Thousand USD | 432.644% |
| Innovation Pharmaceuticals Inc. | -1.25 Million USD | -105.603% |
| Neutra Corp. | 52.18 Thousand USD | 5024.659% |
| Windtree Therapeutics, Inc. | -2.48 Million USD | -3.256% |
| PureTech Health plc | -167.19 Million USD | 98.463% |
| Coeptis Therapeutics, Inc. | -244.9 Thousand USD | -949.387% |
| IXICO plc | -4.44 Million USD | 42.176% |
| IntelGenx Technologies Corp. | 13.21 Million USD | 119.442% |
| Gelesis Holdings, Inc. | 54.85 Million USD | 104.685% |
| CSL Limited | 10.52 Billion USD | 100.024% |
| Cellectis S.A. | -43.81 Million USD | 94.135% |